VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HMNHorace Mann Educators Corporation
$51.60$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHMNFinancials

Horace Mann Educators Corporation (HMN) Financials

30Y historyFree accessUpdated daily

Revenue growth remains stable at 7.3% as of 2026Q1, though underwriting profitability remains sensitive to loss ratio fluctuations that previously reached 76.0% in 2024Q2.

HMN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.66B1.62B1.55B1.43B1.34B1.25B1.29B1.4B1.18B1.17B1.13B1.08B1.06B1.03B1.01B998.3M974.71M937.43M834.82M887M885.84M869.41M878.35M853.7M771.8M804.5M781.2M775.43M779.44M746.98M703.8M
Revenue Growth %5.57%4.81%8.21%6.84%7.26%-3.04%-8.21%19.44%0.4%3.78%4.49%1.86%2.85%2.02%1.25%2.42%3.98%12.29%-5.88%0.13%1.89%-1.02%2.89%10.61%-4.06%2.98%0.75%-0.52%4.35%6.14%-4.97%
Medical Costs & Claims787.3M1.05B1.07B1.08B1.01B841.3M873.4M907.1M953.65M883.13M829.76M778.13M738.38M702.85M691.33M740.74M621.56M598.08M603.33M484.15M462.73M514.18M554.41M583.32M512.16M533.63M0000387.75M
Medical Cost Ratio %47.51%64.8%69.14%75.1%75.21%67.29%67.73%64.57%81.08%75.38%73.5%72.02%69.61%68.15%68.39%74.2%63.77%63.8%72.27%54.58%52.24%59.14%63.12%68.33%66.36%66.33%0%0%0%0%55.09%
Gross Profit869.9M572M478.4M356.8M332.5M409M416.1M497.7M222.54M288.42M299.15M302.32M322.3M328.41M319.48M257.56M353.15M339.35M231.49M402.86M423.11M355.23M323.94M270.38M259.64M270.87M781.2M775.43M779.44M746.98M316.05M
Gross Margin %52.49%35.2%30.86%24.9%24.79%32.71%32.27%35.43%18.92%24.62%26.5%27.98%30.39%31.85%31.61%25.8%36.23%36.2%27.73%45.42%47.76%40.86%36.88%31.67%33.64%33.67%100%100%100%100%44.91%
Gross Profit Growth %-19.57%34.08%7.31%-18.7%-1.71%-16.4%123.64%-22.84%-3.59%-1.05%-6.2%-1.86%2.8%24.04%-27.07%4.07%46.59%-42.54%-4.79%19.11%9.66%19.81%4.14%-4.15%-65.33%0.75%-0.52%4.35%136.35%-54.73%
Operating Expenses716.2M370.8M349.8M303.5M316M198.9M256.5M261.3M203.01M199.74M184.92M172.87M176.19M174.35M170.31M162.64M241.86M235.84M231.31M285.79M282.82M261.19M254.18M251.18M251.94M242.57M771.48M682.07M662.66M627.34M-377.25M
OpEx / Revenue %43.22%22.82%22.56%21.18%23.56%15.91%19.89%18.6%17.26%17.05%16.38%16%16.61%16.91%16.85%16.29%24.81%25.16%27.71%32.22%31.93%30.04%28.94%29.42%32.64%30.15%98.76%87.96%85.02%83.98%-53.6%
Depreciation & Amortization20.1M27.1M26.4M26.2M27.6M18.4M23.4M15.6M7.36M6.62M000008.58M8.32M8.35M13.96M12.78M6.08M10.24M11.05M11.08M12.51M8.3M6.76M-1M5.3M10.6M13.1M
Combined Ratio %90.73%87.62%91.71%96.28%98.77%83.2%87.62%83.17%98.34%92.43%89.88%88.02%86.22%85.06%85.24%90.49%88.58%88.96%99.98%86.8%84.16%89.18%92.06%97.75%99%96.48%98.76%87.96%85.02%83.98%1.49%
Operating Income153.7M201.2M128.6M53.3M16.5M210.1M159.6M236.4M19.54M88.69M114.23M129.45M146.11M154.07M149.17M94.92M111.29M103.51M178K117.07M140.29M94.04M69.76M19.2M7.7M28.3M9.72M93.35M116.78M119.64M693.3M
Operating Margin %9.27%12.38%8.29%3.72%1.23%16.8%12.38%16.83%1.66%7.57%10.12%11.98%13.78%14.94%14.76%9.51%11.42%11.04%0.02%13.2%15.84%10.82%7.94%2.25%1%3.52%1.24%12.04%14.98%16.02%98.51%
Operating Income Growth %-56.45%141.28%223.03%-92.15%31.64%-32.49%1110.01%-77.97%-22.36%-11.76%-11.4%-5.16%3.28%57.16%-14.71%7.52%58050%-99.85%-16.55%49.18%34.82%263.32%149.35%-72.79%191.12%-89.59%-20.06%-2.39%-82.74%0.99%
EBITDA173.8M228.3M155M79.5M44.1M228.5M183M252M26.89M95.3M126.04M142.57M160.31M168.3M163.42M103.5M119.61M111.86M14.13M129.85M146.37M104.29M80.8M30.28M20.21M36.6M16.48M92.35M122.08M130.24M706.4M
EBITDA Margin %10.49%14.05%10%5.55%3.29%18.28%14.19%17.94%2.29%8.13%11.16%13.2%15.11%16.32%16.17%10.37%12.27%11.93%1.69%14.64%16.52%12%9.2%3.55%2.62%4.55%2.11%11.91%15.66%17.44%100.37%
Interest Expense27.5M36.4M34.6M29.7M19.4M13.9M15.2M15.6M13M11.95M11.81M13.12M14.2M14.24M14.25M14.01M13.95M13.97M14.46M14.06M135.62M124.74M115.49M6.34M8.52M9.3M102.77M101.35M104.26M106.64M10.5M
Non-Operating Income-27.5M-36.4M-34.6M-29.7M-19.4M-13.9M-15.2M-15.6M-13M-11.95M-11.81M-13.12M-14.2M-14.24M-14.25M-14.01M-13.95M-13.97M-14.46M-14.06M-135.62M-124.74M-115.49M-6.34M-8.52M-9.3M-102.77M-101.35M-104.26M-106.64M682.8M
Pretax Income203.9M201.2M128.6M53.3M16.5M210.1M159.6M236.4M19.54M88.69M114.23M129.45M146.11M154.07M149.17M94.92M111.29M103.51M178K117.07M140.29M94.04M69.76M19.2M7.7M28.3M9.72M93.35M116.78M119.64M100.6M
Pretax Margin %12.3%12.38%8.29%3.72%1.23%16.8%12.38%16.83%1.66%7.57%10.12%11.98%13.78%14.94%14.76%9.51%11.42%11.04%0.02%13.2%15.84%10.82%7.94%2.25%1%3.52%1.24%12.04%14.98%16.02%14.29%
Income Tax38.8M39.1M25.8M8.3M-3.3M39.7M26.3M52M1.19M-80.77M30.47M35.97M41.87M43.17M45.31M24.41M30.43M30.02M-10.74M34.28M41.59M16.77M13.44M204K-3.67M4.02M-2.44M28.85M31.47M32.58M26.8M
Effective Tax Rate %19.03%19.43%20.06%15.57%-20%18.9%16.48%22%6.11%-91.08%26.67%27.79%28.66%28.02%30.37%25.72%27.34%29%-6033.15%29.28%29.64%17.83%19.27%1.06%-47.64%14.22%-25.08%30.9%26.95%27.23%26.64%
Net Income165.1M162.1M102.8M45M19.8M170.4M133.3M184.4M18.34M169.46M83.77M93.48M104.24M110.89M103.87M70.51M80.86M73.49M10.92M82.79M98.71M77.27M56.31M19M11.33M25.6M20.84M44.51M85.31M83.58M64.6M
Net Margin %9.96%9.98%6.63%3.14%1.48%13.63%10.34%13.13%1.56%14.46%7.42%8.65%9.83%10.75%10.28%7.06%8.3%7.84%1.31%9.33%11.14%8.89%6.41%2.23%1.47%3.18%2.67%5.74%10.95%11.19%9.18%
Net Income Growth %44.19%57.68%128.44%127.27%-88.38%27.83%-27.71%905.29%-89.18%102.3%-10.39%-10.32%-6%6.77%47.32%-12.81%10.04%573.13%-86.81%-16.13%27.74%37.22%196.38%67.65%-55.73%22.83%-53.17%-47.83%2.08%29.37%-12.58%
EPS (Diluted)4.013.902.481.090.473.393.224.400.444.082.022.202.472.662.511.701.971.810.271.862.191.671.250.440.280.630.511.071.951.801.43
EPS Growth %44.2%57.26%127.52%131.91%-86.14%5.28%-26.82%900%-89.22%101.98%-8.18%-10.93%-7.14%5.98%47.65%-13.71%8.84%570.37%-85.48%-15.07%31.14%33.6%184.09%57.14%-55.56%23.53%-52.34%-45.13%8.33%25.87%104.29%
EPS (Basic)-3.932.491.090.483.453.224.470.454.162.082.302.552.742.641.772.051.880.271.922.291.801.320.440.280.630.511.081.971.821.44
Diluted Shares Outstanding41.2M41.6M41.5M41.4M41.8M42.2M42M41.9M41.89M41.56M41.48M42.42M42.23M41.63M41.39M41.44M41.01M40.53M40.59M44.61M45.77M47.88M47.35M43.18M40.48M40.63M40.97M41.71M43.84M46.52M45.22M

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

P&C underwriting margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Amidst Niche Stability

According to the provided quarterly data, Horace Mann Educators Corporation has maintained a consistent revenue growth trajectory, with the most recent period showing a 7.3% year-over-year increase, suggesting that the company's specialized educator-focused distribution model continues to capture market share despite broader industry competitive pressures.

The revenue growth appears to be supported by the company's unique institutional access within K-12 school districts, which likely insulates it from the aggressive pricing wars seen in mass-market P&C insurance. Investors should monitor whether this growth rate remains sustainable as the company attempts to scale its supplemental benefits segment without diluting its core educator value proposition.

Underwriting Profitability and Combined Ratio

As reported in the financial statements, the combined ratio has fluctuated significantly, reaching a peak of 98.8% in 2024Q2 before improving to 89.1% by 2025Q4, which indicates that underwriting profitability remains sensitive to periodic spikes in loss costs and claims activity within the P&C segment.

The volatility in the combined ratio suggests that the company's underwriting discipline is frequently tested by external inflationary pressures, particularly in auto repair and medical costs. While the recent improvement toward sub-90% levels is encouraging, the historical variance implies that the company's margin profile may remain susceptible to unpredictable weather-related events or social inflation.

Operational Recovery from 2024 Lows

Based on the quarterly income statement data, 2024Q2 represented a critical inflection point where the company experienced a sharp contraction in operating income to $4.6 million, likely driven by elevated loss ratios that have since normalized in subsequent reporting periods through 2026Q1.

This period of extreme margin compression highlights the inherent risks of the P&C business model when loss costs outpace premium adjustments. The subsequent recovery suggests that management's corrective actions, potentially including rate increases or stricter underwriting standards, have been effective in restoring profitability to more normalized levels.

Underwriting Resilience Versus Inflationary Headwinds

While the company demonstrates a strong ability to maintain institutional relationships, the persistent loss ratio volatility, which reached as high as 76.0% in 2024Q2, warrants further investigation into whether current premium pricing is sufficient to offset long-term inflationary trends in the P&C insurance sector.

The reliance on a captive agency force provides a unique moat, but it also creates a fixed-cost burden that may limit the company's ability to rapidly pivot during periods of high claims inflation. Investors should remain cautious regarding whether the current profitability levels are sustainable if the P&C segment continues to face unpredictable loss cost cycles.

HMN — Frequently Asked Questions

Quick answers to the most common questions about buying HMN stock.

What was Horace Mann Educators Corporation's (HMN) revenue in 2025?

For fiscal year 2025, Horace Mann Educators Corporation (HMN) reported total revenue of $1.62B. This represents a 130.9% increase compared to $703.8M in 1996.

Is Horace Mann Educators Corporation (HMN) profitable?

Horace Mann Educators Corporation (HMN) is profitable, generating $162.1M in net income for the fiscal year ending 2025 with a net profit margin of 10.0%.

What is Horace Mann Educators Corporation's operating profit margin?

Horace Mann Educators Corporation (HMN) reported an operating income of $201.2M, resulting in an operating profit margin of 12.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Horace Mann Educators Corporation's gross profit and gross margin?

Horace Mann Educators Corporation (HMN) generated $572.0M in gross profit for the year, representing a gross profit margin of 35.2%. This demonstrates the company's core pricing power and production efficiency.